Dexcom, Inc. 8-K Report: Key Insights & Stock Information for Investors

Based on the provided section of the financial report, here are the key insights and important information extracted:
- Entity Information:
- Company Name: Dexcom, Inc.
- CIK (Central Index Key): 0001093557
- State of Incorporation: Delaware (DE)
- SEC File Number: 000-51222
- IRS Employer Identification Number: 33-0857544
- Address: 6340 Sequence Drive, San Diego, CA 92121
- Phone Number: 858-200-0200
- Filing Details:
- Filing Type: 8-K (Current Report)
- Filing Date: May 1, 2025
- Stock Information:
- Type of Stock: Common Stock
- Par Value: $0.001 per share
- Ticker Symbol: DXCM
- Exchange: NASDAQ
- Reporting Period:
- Start Date: May 1, 2025
- End Date: May 1, 2025
Summary Insights:
- The report is a Form 8-K, which typically provides current reports of significant events that shareholders should know about.
- Dexcom, Inc. is actively listed on the NASDAQ under the ticker DXCM.
- The filing date aligns with the reporting period, suggesting that this is either a timely disclosure of a material event or a periodic update required by the SEC.
This information is crucial for investors, analysts, and stakeholders who track the company's performance and compliance with regulatory requirements.